Surgical Science surges 25 percent after a sharp revenue boost and a substantial profit improvement. The company also downplays the impact of a terminated contract that caused the stock to collapse last year.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Surgical Science surges 25 percent after a sharp revenue boost and a substantial profit improvement. The company also downplays the impact of a terminated contract that caused the stock to collapse last year.